✦ LIBER ✦

PP-064 A tenofovir therapy HBV mathematical model for HBeAg negative and positive patient

✍ Scribed by Man Li; Yongmei Su

Book ID: 118617175
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 56 KB
Volume: 13
Category: Article
ISSN: 1201-9712
DOI: 10.1016/s1201-9712(09)60458-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PP-102 A time-delay HBV therapy mathemat

PP-102 A time-delay HBV therapy mathematical model for entecavir and adefovir

✍ Y.M. Su; L.Q. Min 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 68 KB

421 A new bio-mathematical model to desc

421 A new bio-mathematical model to describe the dynamics of HBV-DNA and infected hepatocytes in HBEAG-negative/anti-HBE-positive chronic hepatitis B patients treated with peginterferon alfa-2A (40KD) (PEGASYS®), lamivudine, or PEGASYS® plus lamivudine combin

✍ P. Colombatto; R. Bizzarri; L. Civitano; F. Oliveri; F. Bonino; G. Germanidis; P 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Increased detection of HBV DNA in HBsAg-

Increased detection of HBV DNA in HBsAg-positive and HBsAg-negative South African HIV/AIDS patients enrolling for highly active antiretroviral therapy at a Tertiary Hospital

✍ Azwidowi Lukhwareni; Rosemary J. Burnett; S. Gloria Selabe; M. Olga Mzileni; M. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

## Abstract This retrospective study investigated the prevalence of hepatitis B virus (HBV) in 192 stored sera from human immunodeficiency virus (HIV) positive South African patients initiating antiretroviral therapy (ART), and explored the implications of HBV–HIV co‐infection on laboratory diagnos